Technical analysis of Calumet Inc. (CLMT): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Calumet, Inc. engages in the manufacturing, formulation, and sale of specialty branded products and renewable fuel. It operates through the following segments: Specialty Products and Solutions, Montana/Renewables, Performance Brands, and Corporate. The Specialty Products & Solutions segment consists of customer-focused solutions and formulation businesses. The Montana/Renewables segment is composed of a Great Falls specialty asphalt facility and Montana Renewables facility.
Price Performance
| 1 month | -15.47% |
| 3 months | +16.07% |
| Year-to-date | +135.18% |
| 1 year | +132.60% |
| 3 years | +235.70% |
| 5 years | +345.05% |
| 10 years | +1337.85% |
52-Week Range
| 52-week High | $59.61 |
| 52-week Low | $17.85 |
| Avg Volume (90d) | 1.3M |
Technical Indicators
| SMA 50 | $53.70 |
| SMA 200 | $38.66 |
| Beta | 0.85 |
| 30-day Volatility (annualised) | 46.4% |
| Price vs SMA 50 | -13.0% |
| Price vs SMA 200 | +20.9% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $19.87 | |
| 2026-01 | $22.41 | +12.8% |
| 2026-02 | $26.96 | +20.3% |
| 2026-03 | $35.90 | +33.2% |
| 2026-04 | $32.72 | -8.9% |
| 2026-05 | $35.47 | +8.4% |
| 2026-06 | $36.02 | +1.6% |
| 2026-07 | $44.19 | +22.7% |
| 2026-08 | $49.73 | +12.5% |
| 2026-09 | $52.38 | +5.3% |
| 2026-10 | $49.65 | -5.2% |
| 2026-11 | $46.73 | -5.9% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-06 | $1.63 | $1.34B |
| 2026-08-07 | $0.07 | $1.12B |
| 2026-05-08 | $-0.57 | $1.00B |
| 2026-02-27 | $-0.67 | $1.06B |
| 2025-11-07 | $-0.35 | $1.05B |
| 2025-08-08 | $-0.44 | $925M |
| 2025-05-09 | $-0.41 | $891M |
Price
| Price | $46.73 (closing price, November 2, 2026) |
| Market Cap | $4.1B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | -3.60 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -1.99 |
| Current Ratio | 0.84 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 1.12 |